Separation systems for commercial biotechnology are becoming popular due to extensive research in the field of biotechnology to introduce new products.
In addition, these systems experience demand across different sectors such as chemical, plastics, and agro-processing due to growing adoption of highly advanced single-use bioprocessing systems. Commercial separation systems in the field of biotech find applications in:
In addition, these systems experience demand across different sectors such as chemical, plastics, and agro-processing due to growing adoption of highly advanced single-use bioprocessing systems. Commercial separation systems in the field of biotech find applications in:
· Pharmaceuticals
· Mammalian Cell Cultures
· Enzymes
· Vaccines
· Proteins
· Human Blood Plasma Fractionation
· Hormones/Insulin
· Agriculture
· Food and cosmetics
Constant Developments to Spur Pharmaceutical Applications
The pharmaceutical applications were the largest application segment for separation systems for commercial biotechnology. Many factors such as high demand for biotherapies, existing shortage of vaccines on a global level, and extensive research and development for drug innovation are expected to fuel the segment growth over the next few years. Various research organizations, in corporation with industrial partners, aim at developing projects and developing tab-on-a-chip technology for industrial use; particularly in the pharmaceutical sector. Most of the research and development activities are focused on modern microfluidics devices, which can separate biomolecules and this is anticipated to drive the segment expansion over the coming years.
Constant advancements in upstream bioprocessing technology, which enables elimination of biohazardous by-productswhile simplify methods, are also responsible for the growth. For example, Thermo Fischer Scientific’s recently launched bioprocessing technology, Harvestainer Microcarrier Separation System. The new Harvestainer BioProcess Container (BPC) system is a single-use and self-contained solution for harvesting and separating cell culturesthat are grown on microcarrier beads. The new system helps enhance product yields as compared to the conventional methods.
Market Insights
A research report by Grand View Research, Inc. predicts that the global separation systems for commercial biotechnology market would reach $ 39.47 bn. by 2025. This growth can be attributed to the factors such as contribution of prominent companies for boosting commercial production and extensive R&D for novel technological and product development. In addition, growing use of advanced single-use bioprocessing systems in different sectors is also likely to boost the market expansion. Some of the prominent companies in the market are Thermo Fisher Scientific; Shimadzu Corp.; Bio-Rad Laboratories, Inc.; Merck & Co., Inc.; and Hitachi Koki Co., Ltd.
In-Depth Research Report On Automotive Appearance Chemicals Market:
https://www.grandviewresearch.com/industry-analysis/separation-systems-for-commercial-biotechnology-market
No comments:
Post a Comment